USE OF KETOGENIC DIET THERAPY IN EPILEPSY WITH MITOCHONDRIAL DYSFUNCTION: A SYSTEMATIC AND CRITICAL REVIEW
Journal: Biotechnologia Acta (Vol.15, No. 2)Publication Date: 2022-06-30
Authors : R. R. KOCATÜRK A. TEMİZYÜREK E. REIS S. TUR Ş. YILMAZ HA. DEMİRKAYA Ö. Ö. ÖZCAN M. KARAHAN;
Page : 15-36
Keywords : epilepsy; ketogenic diet; mitochondrial dysfunction; treatment.;
Abstract
With the development of molecular techniques over time more than %60 of epilepsy has associated with mitochondrial (mt) dysfunction. Ketogenic diet (KD) has been used in the treatment of epilepsy since the 1920s. Aim. To evaluate the evidence behind KD in mt dysfunction in epilepsy. Methods. Databases PubMed, Google Scholar and MEDLINE were searched in an umbrella approach to 12 March 2021 in English. To identify relevant studies specific search strategies were devised for the following topics: (1) mitochondrial dysfunction (2) epilepsy (3) KD treatment. Results. From 1794 papers, 36 articles were included in analysis: 16 (%44.44) preclinical studies, 11 (%30.55) case reports, 9 (%25) clinical studies. In all the preclinic studies, KD regulated the number of mt profiles, transcripts of metabolic enzymes and encoding mt proteins, protected the mice against to seizures and had an anticonvulsant mechanism. Case reports and clinical trials have reported patients with good results in seizure control and mt functions, although not all of them give good results as well as preclinical. Conclusion. Healthcare institutions, researchers, neurologists, health promotion organizations, and dietitians should consider these results to improve KD programs and disease outcomes for mt dysfunction in epilepsy.
Other Latest Articles
- CHARACTERISTICS OF WOUND INFECTIONS AND METHODS OF THEIR TREATMENT USING PREPARATIONS OF BIOLOGICAL ORIGIN
- BIOTECHNOLOGICAL ASPECTS OF THE DEVELOPMENT OF A LIQUID FORMULATION OF MULTIFUNCTIONAL ENZYBIOTIC ANTISEPTIC
- CYTOTOXIC, ANTIOXIDANT AND ANTIMICROBIAL ACTIVITIES OF Peganum harmala L. EXTRACTS
- CARDIOPROTECTIVE EFFECT OF ENKEPHALINS UNDER IMMOBILIZATION STRESS
- METABOLIC PROFILE AND MECHANISMS OF GABA-TARGETED RECEPTOR PROPOXAZEPAM METABOLIZATION IN HUMAN HEPATOCYTES
Last modified: 2022-06-30 19:43:29